A. Szubert

ZOLEDRONIC ACID (ZOL) SIGNIFICANTLY REDUCES SKELETAL-RELATED EVENTS (SRES) VERSUS CLODRONATE (CLO) IN PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM): RESULTS OF THE MEDICAL RESEARCH COUNCIL (MRC) MYELOMA IX STUDY

G. Morgan, G. Jackson, S. Bell, 2010 .

Evaluating the effects of zoledronic acid (ZOL) on overall survival (OS) in patients (Pts) with multiple myeloma (MM): Results of the Medical Research Council (MRC) Myeloma IX study.

G. Morgan, W. Gregory, M. Drayson, 2010 .

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

A547 MRC Myeloma IX: Preliminary Results from the Non-Intensive Study

G. Morgan, W. Gregory, M. Drayson, 2009 .

A346 Prospective Study of Serum FLC and Other M-Protein Assays: When and How to Measure Response?

G. Morgan, W. Gregory, M. Drayson, 2009 .

MRC Myeloma IX: Preliminary Results from The Intensive Pathway Study

W. Gregory, M. Drayson, F. Ross, 2009 .

Does zoledronic acid (ZOL) reduce skeletal-related events (SREs) and improve progression-free survival (PFS) in patients (Pts) with multiple myeloma (MM) with or without bone disease? MRC myeloma IX study results.

G. Cook, J. Byrne, F. Ross, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Are there benefits to long-term bisphosphonate treatment in multiple myeloma (MM)? Insights from temporal analyses of zoledronic acid (ZOL) versus clodronate (CLO) in the MRC Myeloma IX Trial.

G. Cook, J. Byrne, F. Ross, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities☆

P. Vyas, N. Russell, M. Dennis, 2013, Leukemia research reports.

A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia

P. Cauchy, P. Cockerill, M. Boissinot, 2014, Leukemia.